-
2002
1st safety report of Autologous mononuclear BMCs by Dr. Strauer
▶
-
2003
Mechanistic insights from serial contrast-enhanced magnetic resonance imaging
▶
-
2005
First report in monitoring of bone marrow cell homing into the infarcted human myocardium
▶
-
2005
First postmortem anatomicopathologic and immunohistochemical findings
▶
-
2006
First randomized controlled trial (BOOST trial)
▶
-
2006
First Randomized double blind placebo controlled Multicenter trial (REPAIR-AMI trial)
▶
-
2006
First nagative report
▶
-
2006
First report in Korea (MAGIC Cell-3-DES)
▶
-
2007
First transendocardial injection method (TABMMI study)
▶
-
2009
3-year long-term results after intracoronary injection (ASTAMI)
▶
-
2009
5-year long-term follow-up study (BALANCE study)
▶
-
2009
A Randomized controlled trial injection Mesenchymal Stem Cells (Prochymal)
▶
-
2010
Frist report peidatric experience
▶
-
2010
5-year results from the randomized-controlled BOOST trial-an echocardiographic study
▶
-
2012
Negative result of autologous BMC injection in Chronic Heart Failure The FOCUS-CCTRN Trial
▶
-
2013
First report of Cardiopoietic stem cell therapy in heart failure (C-CURE)
▶
-
2014
Intracoronary Cardiosphere-Derived Cells injection of theapeautic effect (CADUCEUS trial)
▶
-
2015
Retrograde Delivery of Autologous Bone Marrow in Patients With Heart Failure (REVIVE Trial)
▶
-
2016
Autologous CD34+ Cell Therapy for Refractory Angina: 2-Year Outcomes From the ACT34-CMI Study
▶
-
2017
First in-human administration of muscle-derived stem/progenitor cells modified with connexin-43 gene for treatment of advanced chronic heart failure.
▶
-
2017
Dose Comparison Study of Allogeneic Mesenchymal Stem Cells i(The TRIDENT Study)
▶
-
2017
Results of randomzied controlled trial of Cardiopoietic cell therapy (CHART-1 clinical trial)
▶
-
2017
Phase I Clinical Trial of Autologous skeletal myoblast Cell Sheet Transplantation Therapy for Treating Cardiomyopathy
▶
-
2020
The effect of intracoronary infusion of bone marrow-derived mononuclear cells on all-cause mortality in acute myocardial infarction: the BAMI trial
▶
-
2021
5-year long-term outcomes of autologous skeletal myoblast cell-sheet transplantation for end-stage ischemic cardiomyopathy
▶
